What's Happening?
A new study by Humana Healthcare Research, published in Health Affairs Scholar, indicates that favorable selection in Medicare Advantage (MA) plans is significantly lower than previously estimated by MedPAC and other analyses. Favorable selection refers
to the phenomenon where MA enrollees incur lower costs than predicted after risk adjustment. The study found that by using comprehensive encounter data to evaluate the full MA population, favorable selection estimates were reduced by 42%-65%, compared to the 10%-15% range often cited. This methodological refinement suggests that the impact of favorable selection on MA payments may be smaller than previously thought.
Why It's Important?
The study's findings could have substantial implications for Medicare Advantage payment policies. By providing a more accurate estimate of favorable selection, the research challenges existing assumptions that have influenced policy debates. This could lead to adjustments in how MA plans are evaluated and funded, potentially affecting the financial dynamics of the healthcare industry. The use of comprehensive data sets a precedent for more precise assessments in healthcare policy, which could improve the allocation of resources and ensure fairer compensation for MA providers.
What's Next?
The study underscores the need for continued methodological advancements in evaluating MA plans. Policymakers and healthcare providers may need to reassess current models and consider integrating comprehensive data analysis into their evaluations. This could lead to more informed decisions regarding MA payment structures and potentially influence future legislative actions. As the healthcare landscape evolves, ongoing research will be crucial in adapting policies to reflect the true dynamics of MA enrollment and costs.
